Search research articles
Contact Us
Filters
Showing results (81-90 of 103) with videos related to
Page
of 11
Sort By:
Journal of Hepatology
|
January 22, 2022
Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events
Jerome Boursier, Hannes Hagström, Mattias Ekstedt, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 15, 2022
Impact of Type 2 Diabetes on the Accuracy of Noninvasive Tests of Liver Fibrosis With Resulting Clinical Implications
Jérôme Boursier, Clémence M Canivet, Charlotte Costentin, et al.
JHEP Reports : Innovation in Hepatology
|
February 11, 2020
The mid-infrared spectroscopy: A novel non-invasive diagnostic tool for NASH diagnosis in severe obesity
Rodolphe Anty, Marie Morvan, Maëna Le Corvec, et al.
Hepatology (Baltimore, Md.)
|
July 13, 2022
Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLD
Clémence M Canivet, Charlotte Costentin, Katharina M Irvine, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 19, 2020
Reliability Criteria of Two-Dimensional Shear Wave Elastography: Analysis of 4277 Measurements in 788 Patients
Anita Paisant, Sylvain Lemoine, Christophe Cassinotto, et al.
Alimentary Pharmacology & Therapeutics
|
March 27, 2018
Screening for therapeutic trials and treatment indication in clinical practice: MACK-3, a new blood test for the diagnosis of fibrotic NASH
J Boursier, R Anty, L Vonghia, et al.
Diabetes & Metabolism
|
October 17, 2025
Management of patients with type 2 diabetes and MASLD: An overview and joint statement
Yasmina Chouik, Clémence M Canivet, Jean-Baptiste Julla, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 9, 2023
Validation of the Blood Test MACK-3 for the Noninvasive Diagnosis of Fibrotic Nonalcoholic Steatohepatitis: An International Study With 1924 Patients
Clémence M Canivet, Ming-Hua Zheng, Sami Qadri, et al.
Alimentary Pharmacology & Therapeutics
|
April 18, 2018
Safety of sofosbuvir-based regimens after liver transplantation: longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT study
R Anty, G Favre, A Coilly, et al.
JAMA
|
March 21, 2024
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease
Huapeng Lin, Hye Won Lee, Terry Cheuk-Fung Yip, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 103) with videos related to
Sort By:
Page
of 11
Journal of Hepatology
|
January 22, 2022
Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events
Jerome Boursier, Hannes Hagström, Mattias Ekstedt, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 15, 2022
Impact of Type 2 Diabetes on the Accuracy of Noninvasive Tests of Liver Fibrosis With Resulting Clinical Implications
Jérôme Boursier, Clémence M Canivet, Charlotte Costentin, et al.
JHEP Reports : Innovation in Hepatology
|
February 11, 2020
The mid-infrared spectroscopy: A novel non-invasive diagnostic tool for NASH diagnosis in severe obesity
Rodolphe Anty, Marie Morvan, Maëna Le Corvec, et al.
Hepatology (Baltimore, Md.)
|
July 13, 2022
Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLD
Clémence M Canivet, Charlotte Costentin, Katharina M Irvine, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 19, 2020
Reliability Criteria of Two-Dimensional Shear Wave Elastography: Analysis of 4277 Measurements in 788 Patients
Anita Paisant, Sylvain Lemoine, Christophe Cassinotto, et al.
Alimentary Pharmacology & Therapeutics
|
March 27, 2018
Screening for therapeutic trials and treatment indication in clinical practice: MACK-3, a new blood test for the diagnosis of fibrotic NASH
J Boursier, R Anty, L Vonghia, et al.
Diabetes & Metabolism
|
October 17, 2025
Management of patients with type 2 diabetes and MASLD: An overview and joint statement
Yasmina Chouik, Clémence M Canivet, Jean-Baptiste Julla, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 9, 2023
Validation of the Blood Test MACK-3 for the Noninvasive Diagnosis of Fibrotic Nonalcoholic Steatohepatitis: An International Study With 1924 Patients
Clémence M Canivet, Ming-Hua Zheng, Sami Qadri, et al.
Alimentary Pharmacology & Therapeutics
|
April 18, 2018
Safety of sofosbuvir-based regimens after liver transplantation: longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT study
R Anty, G Favre, A Coilly, et al.
JAMA
|
March 21, 2024
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease
Huapeng Lin, Hye Won Lee, Terry Cheuk-Fung Yip, et al.
Page
of 11